Virus News and Research

RSS

A virus is a microscopic infectious agent that can reproduce only inside a host cell. Viruses infect all types of organisms: from animals and plants, to bacteria and archaea. Since the initial discovery of tobacco mosaic virus by Martinus Beijerinck in 1898, more than 5,000 types of virus have been described in detail, although most types of virus remain undiscovered. Viruses are ubiquitous, as they are found in almost every ecosystem on Earth, and are the most abundant type of biological entity on the planet. The study of viruses is known as virology, and is a branch of microbiology.

Study assesses the effectiveness of T-cell immune response to different SARS-CoV-2 variants

New mutations of the SARS-CoV-2 virus have been emerging continuously, enabling a more potent spread of the virus and allowing it to evade antibodies.

16 Aug 2021

New system solves 3D structures of RNA-only molecules with unprecedented speed and accuracy

The single-stranded genetic material RNA is best known for guiding the assembly of proteins in our cells and carrying the genetic code for viruses like SARS-CoV-2 and HIV.

16 Aug 2021

Scientists develop new tool to identify neuronal proteins in animal models

Scientists, for the first time, developed a successful method for pinpointing proteins within different kinds of neurons in the brain of a living animal.

16 Aug 2021

Pest attack order impacts plant's defenses and nutritional quality

The dining time of different insects impacts a plant's defenses and nutritional quality-;a complexity uncovered in new research with implications for pest management strategies.

12 Aug 2021

Understanding computational fluid dynamics can inform more effective design of drug delivery devices

Increased air pollution in recent years has not only contributed to deteriorating environmental conditions in cities across the globe.

12 Aug 2021

New study could help design more effective vaccines against various COVID-19 variants

Scientists have discovered that individuals recovering from COVID-19 produce identical clones, or groups, of antibody-producing white blood cells.

From Vanderbilt University 12 Aug 2021

Researchers identify virus-derived variations in human genomes

Three geneticists from RIKEN identified previously undetected snippets of genetic material from viruses that were hidden in human DNA.

12 Aug 2021

New technique to hunt down mutations that cause cancer drug resistance

Using a virus to purposely mutate genes that produce cancer-driving proteins could shed light on the resistance that inevitably develops to cancer drugs that target them, a new study led by UT Southwestern scientists suggests.

11 Aug 2021

Scientists show how lab-grown beating heart cells are vulnerable to SARS-CoV-2 infection

Cambridge scientists have grown beating heart cells in the lab and shown how they are vulnerable to SARS-CoV-2 infection. In a study published in Communications Biology, they used this system to show that an experimental peptide drug called DX600 can prevent the virus entering the heart cells.

6 Aug 2021

Study highlights novel approach for designing anti-viral drugs

Scientists are exploring a novel screening approach that concentrates on the recognition of virus-specific morphological changes in virus-infected cells.

4 Aug 2021

Researchers conduct molecular analysis of the 2021 Bundibugyo virus outbreak

New research offers insight into the origins of the 2012 Bundibugyo viral disease outbreak in the Democratic Republic of the Congo.

4 Aug 2021

Researchers devise a new method for safer delivery of RNA drugs

Scientists have developed and tested a library of lipid-based compounds for the safe and effective delivery of RNA drugs to the lungs.

3 Aug 2021

T cell-depleted macaques can mount potent memory responses against SARS-CoV-2

New research conducted in monkeys reveals that T cells are not critical for the recovery of primates from acute COVID-19 infections.

28 Jul 2021

Researchers develop repository showcasing antibody activity on spike protein variants

Scientists have created an “atlas” that charts how 152 different antibodies attack a major piece of the SARS-CoV-2 machinery, the spike protein.

27 Jul 2021

Study employs llama nanobodies to hunt human cytomegalovirus

Researchers created a “nanobody”, a small fragment of a llama antibody, that can evade human cytomegalovirus as it hides away from the immune system.

26 Jul 2021

Already characterized active substances exhibit unexpected effects

Every innovative drug starts with the search for an active substance targeting key players in disease-related processes.

23 Jul 2021

Study reveals SARS-CoV-2 variant is less sensitive to inhibition by antibodies

SARS-CoV-2 is still a major threat to humankind. The constant emergence of variants makes the threat made by the virus difficult to estimate. The SARS-CoV-2 variant B.1.617 spread in India and gave rise to the Delta variant, B.1.617.2, which is now dominant in numerous countries.

23 Jul 2021

Virus News and Research

Study assesses the effectiveness of T-cell immune response to different SARS-CoV-2 variants

New system solves 3D structures of RNA-only molecules with unprecedented speed and accuracy

Scientists develop new tool to identify neuronal proteins in animal models

Pest attack order impacts plant's defenses and nutritional quality

Understanding computational fluid dynamics can inform more effective design of drug delivery devices

New study could help design more effective vaccines against various COVID-19 variants

Researchers identify virus-derived variations in human genomes

New technique to hunt down mutations that cause cancer drug resistance

Scientists show how lab-grown beating heart cells are vulnerable to SARS-CoV-2 infection

Study highlights novel approach for designing anti-viral drugs

Researchers conduct molecular analysis of the 2021 Bundibugyo virus outbreak

Researchers devise a new method for safer delivery of RNA drugs

T cell-depleted macaques can mount potent memory responses against SARS-CoV-2

Researchers develop repository showcasing antibody activity on spike protein variants

Study employs llama nanobodies to hunt human cytomegalovirus

Already characterized active substances exhibit unexpected effects

Study reveals SARS-CoV-2 variant is less sensitive to inhibition by antibodies

Natto, a Japanese fermented soybean dish, may hold the key to COVID-19 treatment

SARS-CoV-2 variant B.1.617 can infect lung and intestinal cells more efficiently than the original virus

L452R mutation of SARS-CoV-2 spike protein is involved in cellular immunity evasion

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics